Coronary Heart Disease (CHD) in elderly patients: Which drug to choose, ticagrelor and clopidogrel? a systematic review and meta-analysis of randomized controlled trials

• Main Authors: Akkaif, Mohammed Ahmed, Sha'aban, Abubakar, Daud, Nur Aizati Athirah, Yunusa, Ismaeel, Ng, Mei Li, Kader, Muhamad Ali Sk Abdul, Noor, Dzul Azri Mohamed, Ibrahim, Baharudin
• Format: Article
• Published: MDPI 2021
• Subjects: R Medicine; RC Internal medicine; RS Pharmacy and materia medica
• Online Access: http://eprints.um.edu.my/33884/

A new generation P2Y12 receptor inhibitor (ticagrelor) is recommended in current therapeutic guidelines to treat patients with coronary heart disease (CHD). However, it is unknown if ticagrelor is more effective than clopidogrel in elderly patients. Therefore, a systematic review was done to assess...